Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States
Objectives: To evaluate the cost-effectiveness of a booster strategy in the United States. Methods: We developed a decision-analytic Markov model of COVID-19 to evaluate the cost-effectiveness of a booster strategy of the Pfizer-BioNTech BNT162b2 (administered 6 months after the second dose) among o...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2022-06-01
|
| coleção: | International Journal of Infectious Diseases |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S1201971222001680 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
